Logo image of BAM

BROOKFIELD ASSET MGMT-A (BAM) Stock Fundamental Analysis

USA - NYSE:BAM - CA1130041058 - Common Stock

58.08 USD
+0.3 (+0.52%)
Last: 10/7/2025, 1:23:08 PM
Fundamental Rating

5

Taking everything into account, BAM scores 5 out of 10 in our fundamental rating. BAM was compared to 238 industry peers in the Capital Markets industry. BAM has an excellent financial health rating, but there are some minor concerns on its profitability. While showing a medium growth rate, BAM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BAM was profitable.
BAM had a positive operating cash flow in the past year.
In the past 5 years BAM has always been profitable.
BAM had a positive operating cash flow in 4 of the past 5 years.
BAM Yearly Net Income VS EBIT VS OCF VS FCFBAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

BAM has a Return On Assets of 8.71%. This is amongst the best in the industry. BAM outperforms 85.29% of its industry peers.
BAM's Return On Equity of 13.61% is fine compared to the rest of the industry. BAM outperforms 71.43% of its industry peers.
BAM has a Return On Invested Capital of 7.21%. This is in the better half of the industry: BAM outperforms 78.99% of its industry peers.
BAM had an Average Return On Invested Capital over the past 3 years of 1.40%. This is significantly below the industry average of 7.64%.
The 3 year average ROIC (1.40%) for BAM is below the current ROIC(7.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.71%
ROE 13.61%
ROIC 7.21%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.4%
ROIC(5y)3.71%
BAM Yearly ROA, ROE, ROICBAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

BAM's Profit Margin of 57.13% is amongst the best of the industry. BAM outperforms 94.96% of its industry peers.
BAM's Profit Margin has improved in the last couple of years.
The Operating Margin of BAM (51.12%) is better than 86.55% of its industry peers.
BAM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 51.12%
PM (TTM) 57.13%
GM N/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
BAM Yearly Profit, Operating, Gross MarginsBAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200 400 600 800 1K

7

2. Health

2.1 Basic Checks

BAM has more shares outstanding than it did 1 year ago.
BAM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BAM has been reduced compared to a year ago.
BAM Yearly Shares OutstandingBAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BAM Yearly Total Debt VS Total AssetsBAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B

2.2 Solvency

BAM has an Altman-Z score of 10.19. This indicates that BAM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BAM (10.19) is better than 93.28% of its industry peers.
The Debt to FCF ratio of BAM is 2.32, which is a good value as it means it would take BAM, 2.32 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.32, BAM belongs to the best of the industry, outperforming 86.13% of the companies in the same industry.
BAM has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
BAM has a Debt to Equity ratio of 0.22. This is in the better half of the industry: BAM outperforms 74.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 2.32
Altman-Z 10.19
ROIC/WACCN/A
WACCN/A
BAM Yearly LT Debt VS Equity VS FCFBAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B

2.3 Liquidity

BAM has a Current Ratio of 1.31. This is a normal value and indicates that BAM is financially healthy and should not expect problems in meeting its short term obligations.
BAM has a Current ratio (1.31) which is comparable to the rest of the industry.
BAM has a Quick Ratio of 1.31. This is a normal value and indicates that BAM is financially healthy and should not expect problems in meeting its short term obligations.
BAM has a Quick ratio of 1.31. This is in the better half of the industry: BAM outperforms 60.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
BAM Yearly Current Assets VS Current LiabilitesBAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.94% over the past year.
BAM shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.95% yearly.
Looking at the last year, BAM shows a very strong growth in Revenue. The Revenue has grown by 531.03%.
Measured over the past years, BAM shows a very negative growth in Revenue. The Revenue has been decreasing by -26.01% on average per year.
EPS 1Y (TTM)15.94%
EPS 3Y-15.34%
EPS 5Y-22.95%
EPS Q2Q%23.53%
Revenue 1Y (TTM)531.03%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-5.05%

3.2 Future

The Earnings Per Share is expected to grow by 15.67% on average over the next years. This is quite good.
BAM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.22% yearly.
EPS Next Y13.23%
EPS Next 2Y14.68%
EPS Next 3Y15.67%
EPS Next 5YN/A
Revenue Next Year11.73%
Revenue Next 2Y12.84%
Revenue Next 3Y13.22%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BAM Yearly Revenue VS EstimatesBAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
BAM Yearly EPS VS EstimatesBAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 36.30 indicates a quite expensive valuation of BAM.
Based on the Price/Earnings ratio, BAM is valued a bit more expensive than the industry average as 75.63% of the companies are valued more cheaply.
BAM is valuated rather expensively when we compare the Price/Earnings ratio to 27.90, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 30.46 indicates a quite expensive valuation of BAM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BAM indicates a slightly more expensive valuation: BAM is more expensive than 70.59% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BAM to the average of the S&P500 Index (23.36), we can say BAM is valued slightly more expensively.
Industry RankSector Rank
PE 36.3
Fwd PE 30.46
BAM Price Earnings VS Forward Price EarningsBAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

BAM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 98.67
EV/EBITDA N/A
BAM Per share dataBAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BAM may justify a higher PE ratio.
A more expensive valuation may be justified as BAM's earnings are expected to grow with 15.67% in the coming years.
PEG (NY)2.74
PEG (5Y)N/A
EPS Next 2Y14.68%
EPS Next 3Y15.67%

3

5. Dividend

5.1 Amount

BAM has a Yearly Dividend Yield of 2.21%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 8.50, BAM is paying slightly less dividend.
BAM's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.21%

5.2 History

BAM has paid a dividend for at least 10 years, which is a reliable track record.
As BAM did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years6
Div Non Decr Years6
BAM Yearly Dividends per shareBAM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

BAM pays out 122.97% of its income as dividend. This is not a sustainable payout ratio.
DP122.97%
EPS Next 2Y14.68%
EPS Next 3Y15.67%
BAM Yearly Income VS Free CF VS DividendBAM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
BAM Dividend Payout.BAM Dividend Payout, showing the Payout Ratio.BAM Dividend Payout.PayoutRetained Earnings

BROOKFIELD ASSET MGMT-A

NYSE:BAM (10/7/2025, 1:23:08 PM)

58.08

+0.3 (+0.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners17.36%
Inst Owner Change0%
Ins Owners1.9%
Ins Owner ChangeN/A
Market Cap95.12B
Analysts67.27
Price Target65.18 (12.22%)
Short Float %3.87%
Short Ratio7.67
Dividend
Industry RankSector Rank
Dividend Yield 2.21%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP122.97%
Div Incr Years6
Div Non Decr Years6
Ex-Date08-29 2025-08-29 (0.4375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.8%
Min EPS beat(2)-1.13%
Max EPS beat(2)6.73%
EPS beat(4)3
Avg EPS beat(4)3.2%
Min EPS beat(4)-1.13%
Max EPS beat(4)6.73%
EPS beat(8)5
Avg EPS beat(8)2.65%
EPS beat(12)8
Avg EPS beat(12)3.3%
EPS beat(16)10
Avg EPS beat(16)14.49%
Revenue beat(2)0
Avg Revenue beat(2)-16.78%
Min Revenue beat(2)-17.67%
Max Revenue beat(2)-15.9%
Revenue beat(4)0
Avg Revenue beat(4)-12.82%
Min Revenue beat(4)-17.67%
Max Revenue beat(4)-0.58%
Revenue beat(8)0
Avg Revenue beat(8)-9.19%
Revenue beat(12)1
Avg Revenue beat(12)-15.43%
Revenue beat(16)3
Avg Revenue beat(16)127.5%
PT rev (1m)1.94%
PT rev (3m)10.92%
EPS NQ rev (1m)-0.14%
EPS NQ rev (3m)0.28%
EPS NY rev (1m)0.57%
EPS NY rev (3m)-1.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.82%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 36.3
Fwd PE 30.46
P/S 38.65
P/FCF 98.67
P/OCF 98.47
P/B 9.21
P/tB 9.21
EV/EBITDA N/A
EPS(TTM)1.6
EY2.75%
EPS(NY)1.91
Fwd EY3.28%
FCF(TTM)0.59
FCFY1.01%
OCF(TTM)0.59
OCFY1.02%
SpS1.5
BVpS6.31
TBVpS6.31
PEG (NY)2.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.71%
ROE 13.61%
ROCE 9.83%
ROIC 7.21%
ROICexc 7.47%
ROICexgc 7.81%
OM 51.12%
PM (TTM) 57.13%
GM N/A
FCFM 39.17%
ROA(3y)9%
ROA(5y)7.21%
ROE(3y)13.06%
ROE(5y)12.5%
ROIC(3y)1.4%
ROIC(5y)3.71%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.93%
ROCE(5y)4.85%
ROICexcg growth 3Y-36.28%
ROICexcg growth 5YN/A
ROICexc growth 3Y-36.35%
ROICexc growth 5YN/A
OM growth 3Y-30.79%
OM growth 5Y-18.69%
PM growth 3Y22.85%
PM growth 5Y4.98%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 2.32
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 21.69
Cash Conversion N/A
Profit Quality 68.56%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 10.19
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)18.12%
Cap/Sales(5y)11.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.94%
EPS 3Y-15.34%
EPS 5Y-22.95%
EPS Q2Q%23.53%
EPS Next Y13.23%
EPS Next 2Y14.68%
EPS Next 3Y15.67%
EPS Next 5YN/A
Revenue 1Y (TTM)531.03%
Revenue growth 3Y-46.15%
Revenue growth 5Y-26.01%
Sales Q2Q%-5.05%
Revenue Next Year11.73%
Revenue Next 2Y12.84%
Revenue Next 3Y13.22%
Revenue Next 5YN/A
EBIT growth 1Y2319.23%
EBIT growth 3Y-62.73%
EBIT growth 5Y-39.83%
EBIT Next Year14.6%
EBIT Next 3Y17.48%
EBIT Next 5YN/A
FCF growth 1Y139.98%
FCF growth 3Y-25.34%
FCF growth 5Y-6.68%
OCF growth 1Y140.66%
OCF growth 3Y-24.26%
OCF growth 5Y-5.43%